Diabetes Mellitus, Type 1: all 3,614 studies
Page 31 of 37. Open to participants first (586), then studies with results posted, then the rest; newest registration first within each.
- Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative OutcomesCompletedNCT01490619Not applicable
- Surveillance Study of NovoRapid® for New Drug Re-examinationCompletedNCT01490112
- Use of Diazoxide in Acute HypoglycaemiaCompletedNCT01488136Phase 4
- Special Survey for Type 1 or Type 2 Diabetic PatientsCompletedNCT01487408
- Special Survey for Paediatric SubjectsCompletedNCT01487382
- Special Survey of Production of Insulin Aspart Specific AntibodyCompletedNCT01487369
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
- Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 DiabetesCompletedNCT01486381Phase 3
- Controlled Insulin Delivery: Combining Technology With TreatmentCompletedNCT01484457Early Phase 1
- Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 DiabetesWithdrawnNCT01477476Phase 2
- Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)CompletedNCT01472406Early Phase 1
- Can Glucose Monitoring Improve (CGMi Study)CompletedNCT01472159Not applicable
- Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring TestingCompletedNCT01470807Not applicable
- A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01469143Phase 1
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedNCT01467323Phase 3
- Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedNCT01467141Phase 4
- Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 DiabetesCompletedNCT01464099Phase 1
- Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisCompletedNCT01461616Phase 3
- OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277TerminatedNCT01460251Phase 3
- A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCompletedNCT01455142Phase 1
- Effect of CSII and CGM on Progression of Late Diabetic ComplicationsCompletedNCT01454700Phase 4
- Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical PracticeCompletedNCT01454024
- Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type ICompletedNCT01452893
- Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisCompletedNCT01452815Phase 2
- Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - PadovaCompletedNCT01447992Early Phase 1
- Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - MontpellierCompletedNCT01447979Early Phase 1
- Prospective Assessment of Meos Telemedicine E-portal on Ambulatory Care of Type 1 Diabetic PatientsStatus unknownNCT01447940Phase 3
- Mobile Phone Applications and Quality of LifeCompletedNCT01444534Not applicable
- DiaCon Overnight Closed-Loop Glucose Control StudyCompletedNCT01444443Not applicable
- Evaluation of Interests of FIT Therapy on Diabetics Children Insulin-dependentStatus unknownNCT01443741Phase 2
- Comparing Long-acting Insulins During Exercise in Type 1 DiabetesStatus unknownNCT01440439Phase 4
- Closing the Loop in Adults With Type 1 Diabetes in the Home SettingCompletedNCT01440140Phase 2
- Changing Diabetes® World TourCompletedNCT01437072
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 DiabetesCompletedNCT01435642
- Pramlintide Combined With Model Predictive Control AlgorithmTerminatedNCT01434862Not applicable
- Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel FormationCompletedNCT01429467Not applicable
- The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes MellitusWithdrawnNCT01425255
- Health Care for Type 1 Diabetes in Developing WorldCompletedNCT01424046Not applicable
- Diagnosis and Physiopathology of Insulin AllergyCompletedNCT01407640Not applicable
- Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose MonitorCompletedNCT01407315Phase 1
- Best Timing of Insulin Bolus Before Meals of Different ContentsStatus unknownNCT01406496Not applicable
- Beta Cell Function in (Pre)Type 1 DiabetesStatus unknownNCT01402037Not applicable
- Use of a Telehomecare Program for Young Patients With New Onset Type 1 DiabetesCompletedNCT01401790Not applicable
- Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research SettingCompletedNCT01401751Not applicable
- Managing Insulin Pumps for Exercise - Study 1CompletedNCT01401127
- Pizza-Salami Study in Children and Adolescents With Type 1 DiabetesCompletedNCT01400659Phase 4
- Effect of Fiber Supplementation in Children With Type 1 DiabetesCompletedNCT01399892Not applicable
- Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01399346Phase 1
- Managing Insulin Pumps for Exercise (Study 2)TerminatedNCT01398995Not applicable
- Glycemic Response to Road Cycling in Type 1 DiabetesStatus unknownNCT01398826
- Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsWithdrawnNCT01398670Phase 3
- Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 DiabetesCompletedNCT01397513Phase 4
- Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic GastroparesisCompletedNCT01394055Phase 1
- Type 1 Diabetes and Eating Disorder Diurnal Glucose PatternsTerminatedNCT01390636
- Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 DiabetesCompletedNCT01390480Phase 4
- Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I DiabetesStatus unknownNCT01382459
- Bet Cell Therapy in Diabetes Type 1Status unknownNCT01379729Phase 2
- Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes MellitusStatus unknownNCT01374854Phase 1/2
- Impact of c242T Polymorphism of p22phox in Diabetic type1 NephropathyCompletedNCT01371955
- Extended Follow-Up After Islet Transplantation in T1DCompletedNCT01369082
- Pediatric Diabetics Type 1 Using InsuPatchCompletedNCT01368978Phase 3
- Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DMCompletedNCT01357603Phase 1
- Therapeutic Education in Very Young Children With Diabetes MellitusCompletedNCT01354288Not applicable
- Dose-effect Relationship of Low-dose IL-2 in Type 1 DiabetesCompletedNCT01353833Phase 1/2
- The InsuPad in Daily Life Study - Effect of Local Heating on Postprandial Glucose Excursions Using the InsuPad DeviceCompletedNCT01352767Phase 4
- Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic PatientsWithdrawnNCT01352663Phase 3
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndiaCompletedNCT01351922
- Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 DiabetesCompletedNCT01351857Phase 4
- Stem Cell Educator Therapy in Type 1 DiabetesStatus unknownNCT01350219Phase 2
- Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes MellitusCompletedNCT01349855Phase 1
- Bone Marrow as an Alternative Site for Islet TransplantationCompletedNCT01345227Not applicable
- Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 DiabetesCompletedNCT01341899Phase 2
- Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)CompletedNCT01338922Not applicable
- The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 DiabetesCompletedNCT01337947
- A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) PatientsCompletedNCT01337141Not applicable
- Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 DiabetesCompletedNCT01334151Phase 1
- Effectiveness Study of the Guardian RT in Type 1 DiabeticsCompletedNCT01331343Phase 4
- Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic PatientsStatus unknownNCT01322789Phase 1/2
- ACZ885 in Type 1 Diabetes MellitusWithdrawnNCT01322321Phase 2
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.Active, not recruitingNCT01320345Phase 3
- The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 DiabetesCompletedNCT01319331Phase 1
- Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.CompletedNCT01315171Not applicable
- TAK-329 Glucose Clamp StudyCompletedNCT01311076Phase 1
- Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)No longer availableNCT01309022
- Immunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsTerminatedNCT01308437Phase 3
- MD Logic Pump Advisor -Pediatric StudyCompletedNCT01308164Not applicable
- Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes MellitusCompletedNCT01304537Phase 1/2
- Liraglutide as Additional Treatment in Patients With Type 1 Diabetes MellitusCompletedNCT01299012
- Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 DiabetesCompletedNCT01297946Phase 1/2
- A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1CompletedNCT01296438Phase 1
- Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (The CGM TIME Trial)CompletedNCT01295788Not applicable
- Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 DiabetesCompletedNCT01293461Phase 1/2
- Effect of Dietary Fat on Glycemic Control in Type 1 DiabetesCompletedNCT01292590Not applicable
- FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)CompletedNCT01286350Not applicable
- Hematopoietic Stem Cell Support Versus Insulin in T1DWithdrawnNCT01285934Phase 1/2
- Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes MellitusStatus unknownNCT01285245Phase 2
- Evaluation of the Safety Use of the InsuPatch Device in Daily Life ConditionsCompletedNCT01283425Phase 4
- Study for the Artificial Pancreas Project : Determination of a Tuning Strategy of Metabolic ProfilesCompletedNCT01282567Not applicable
- Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.CompletedNCT01281098Phase 2
- Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot StudyCompletedNCT01279928